{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:26:34Z","timestamp":1790267194247,"version":"4.1.0"},"reference-count":20,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Immunity to rubella virus (RV) is commonly determined by measuring specific immunoglobulin G (RV IgG). However, RV IgG results and their interpretation may vary, depending on the immunoassay, even though most commercial immunoassays (CIAs) have been calibrated against an international standard and results are reported in international units per milliliter. A panel of 322 sera collected from pregnant women that tested negative or equivocal for RV IgG in a prior test (routine screening) was selected. This panel was tested with two reference tests, immunoblotting (IB) and neutralization (Nt), and with 8 CIAs widely used in Europe. IB and Nt gave concordant results on 267\/322 (82.9%) sera. Of these, 85 (26.4%) sera were negative and 182 (56.5%) sera were positive for both tests. All 85 IB\/Nt-negative samples were classified as negative with all CIAs. Of the 182 IB\/Nt-positive samples, 25.3 to 61.5% were classified as equivocal and 6 to 64.8% were classified as positive with the CIAs. Wide variations in titers in international units per milliliter were observed. In our series, more than half of the women considered susceptible to RV based on CIA results tested positive for RV antibodies by IB\/Nt. Our data suggest that (i) sensitivity of CIAs could be increased by considering equivocal results as positive and (ii) the definition of immunity to RV as the 10-IU\/ml usual cutoff as well as the use of quantitative results for clinical decisions may warrant reconsideration. A better standardization of CIAs for RV IgG determination is needed.<\/jats:p>","DOI":"10.1128\/jcm.00383-16","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T04:20:23Z","timestamp":1462422023000},"page":"1720-1725","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":45,"title":["Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays"],"prefix":"10.1128","volume":"54","author":[{"given":"Elise","family":"Bouthry","sequence":"first","affiliation":[{"name":"AP-HP, H\u00f4pital Paul Brousse, Groupe Hospitalier Universitaire Paris-Sud, Virologie, WHO Rubella NRL, National Reference Laboratory for Maternofetal Rubella Infections, University Paris-Sud, INSERM U1193, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Furione","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo, SC Microbiologia e Virologia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Huzly","sequence":"additional","affiliation":[{"name":"Institute of Virology, University Medical Center Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze","family":"Ogee-Nwankwo","sequence":"additional","affiliation":[{"name":"Measles, Mumps, Rubella and Herpesvirus Laboratory Branch, Division of Viral, Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiJuan","family":"Hao","sequence":"additional","affiliation":[{"name":"Measles, Mumps, Rubella and Herpesvirus Laboratory Branch, Division of Viral, Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebola","family":"Adebayo","sequence":"additional","affiliation":[{"name":"Measles, Mumps, Rubella and Herpesvirus Laboratory Branch, Division of Viral, Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Icenogle","sequence":"additional","affiliation":[{"name":"Measles, Mumps, Rubella and Herpesvirus Laboratory Branch, Division of Viral, Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Sarasini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo, SC Microbiologia e Virologia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Revello","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Grangeot-Keros","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Paul Brousse, Groupe Hospitalier Universitaire Paris-Sud, Virologie, WHO Rubella NRL, National Reference Laboratory for Maternofetal Rubella Infections, University Paris-Sud, INSERM U1193, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Vauloup-Fellous","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Paul Brousse, Groupe Hospitalier Universitaire Paris-Sud, Virologie, WHO Rubella NRL, National Reference Laboratory for Maternofetal Rubella Infections, University Paris-Sud, INSERM U1193, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","first-page":"893","volume-title":"Infectious diseases of the fetus and newborn infant","author":"Cooper LZ","unstructured":"Cooper LZ, Alford CA, Jr. Chapter 28. Rubella, p 893\u2013926. In Remington JS, Klein JO, Wilson CB, Baker CJ (ed), Infectious diseases of the fetus and newborn infant, 6th ed. W. B. Saunders, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-111-27749"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-111-27750"},{"key":"e_1_3_3_5_2","first-page":"608","article-title":"Studies of rubella. II. Neutralization of the virus","volume":"93","author":"Parkman PD","year":"1964","unstructured":"Parkman PD, Mundon FK, MCCown JM, Buescher EL. 1964. Studies of rubella. II. Neutralization of the virus. J Immunol 93:608\u2013617.","journal-title":"J Immunol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.148.3668.385"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196703092761006"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2013.4342"},{"key":"e_1_3_3_9_2","volume-title":"Global measles and rubella strategic plan 2012\u20132020","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Global measles and rubella strategic plan 2012\u20132020. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_10_2","volume-title":"Programme standards","author":"UK National Screening Committee","year":"2010","unstructured":"UK National Screening Committee. 2010. Infectious Diseases in Pregnancy Screening Programme. Programme standards. UK National Screening Committee, London, United Kingdom."},{"key":"e_1_3_3_11_2","volume-title":"Investigation, diagnosis and management of viral rash illness or exposure to viral rash illness in pregnancy","author":"HPA Rash Guidance Working Group","year":"2011","unstructured":"HPA Rash Guidance Working Group. 2011. Guidance on viral rash in pregnancy. Investigation, diagnosis and management of viral rash illness or exposure to viral rash illness in pregnancy. Health Protection Agency, London, United Kingdom."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/106.2.170"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00045-15"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00231-08"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00603-12"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00688-12"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.05.046"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.93.8.1274"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00681-13"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.022"},{"key":"e_1_3_3_21_2","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013","volume":"62","author":"CDC","year":"2013","unstructured":"CDC. 2013. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013. MMWR Morb Mortal Wkly Rep 62:1\u201334.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00383-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00383-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T09:46:36Z","timestamp":1646473596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00383-16"}},"subtitle":[],"editor":[{"given":"Y.-W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1128\/JCM.00383-16"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00383-16","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"2016-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}